Circulating Histone Profiles Discriminate Heart Failure Patients With Preserved Versus Reduced Ejection Fraction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652079%3A_____%2F25%3A00644785" target="_blank" >RIV/86652079:_____/25:00644785 - isvavai.cz</a>
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S107191642400808X" target="_blank" >https://www.sciencedirect.com/science/article/pii/S107191642400808X</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Circulating Histone Profiles Discriminate Heart Failure Patients With Preserved Versus Reduced Ejection Fraction
Original language description
Heart failure (HF) is a heterogeneous disease, encompassing a wide range of symptoms. Treatment for HF patients with reduced ejection fraction (HFrEF) lack efficacy for HF patients with preserved ejection fraction (HFpEF). Moreover, HFpEF and HFrEF present different etiologies and comorbidities. The diagnosis of HFpEF remains a challenge, with score-based algorithms showing varying diagnostic performance. Furthermore, levels of BNP and/or NT-proBNP are below detection threshold in approximately 20% of the HFpEF patients. Circulating histones, released in the blood upon cell death, recently emerged as robust biomarkers of inflammation and stroke, but their diagnostic role in HF remains unknown.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů